Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating myelodysplastic syndrome and acute myeloid leukemia with nonfucosylated anti-CD70 antibodies

Methods of treating myelodysplastic syndrome and acute myeloid leukemia with nonfucosylated anti-CD70 antibodies

US Patent 11820827 · Granted Nov 21, 2023

Estimated economic value: $153,262,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
CD47 antibodies and uses thereof for treating cancer2024
T cells with reduced surface fucosylation and methods of making and using the sa2024
Anti-TIGIT antibodies2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2022
Dosage and administration of non-fucosylated anti-CD40 antibodies2021
CD47 antibodies and uses thereof for treating cancer2021